new_0222_0353|TNYA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment
new_0222_0353|TNYA|Long Name|1|1|Tenaya Therapeutics Inc Total Current Assets (Quarterly) (USD)|Tenaya Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Tenaya Therapeutics Inc Inventories (Quarterly) (USD)|Tenaya Therapeutics Inc Net PP&E (Quarterly) (USD)|Tenaya Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Tenaya Therapeutics Inc Total Liabilities (Quarterly) (USD)|Tenaya Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Tenaya Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Tenaya Therapeutics Inc Total Deposits (Quarterly) (USD)|Tenaya Therapeutics Inc Book Value (Quarterly) (USD)|Tenaya Therapeutics Inc Retained Earnings (Quarterly) (USD)|Tenaya Therapeutics Inc Treasury Stock (Quarterly) (USD)|Tenaya Therapeutics Inc EV to Revenues|Tenaya Therapeutics Inc EV to Earnings|Tenaya Therapeutics Inc EV to Free Cash Flow|Tenaya Therapeutics Inc EV to Assets (Quarterly)|Tenaya Therapeutics Inc PS Ratio|Tenaya Therapeutics Inc PE Ratio|Tenaya Therapeutics Inc Price to Book Value|Tenaya Therapeutics Inc PEG Ratio|Tenaya Therapeutics Inc Debt to Equity Ratio|Tenaya Therapeutics Inc Dividend Yield|Tenaya Therapeutics Inc Shareholder Yield (TTM)|Tenaya Therapeutics Inc Percent of Shares Outstanding Short|Tenaya Therapeutics Inc Total Receivables (Quarterly) (USD)|Tenaya Therapeutics Inc Total Payables (Quarterly) (USD)|Tenaya Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Tenaya Therapeutics Inc Return on Invested Capital|Tenaya Therapeutics Inc Quality Ratio Score|Tenaya Therapeutics Inc Momentum Score|Tenaya Therapeutics Inc Beta (1Y)|Tenaya Therapeutics Inc Sustainable Growth Rate (TTM)|Tenaya Therapeutics Inc Institutional Investor Ownership Percentage|Tenaya Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Tenaya Therapeutics Inc Total Employees (Annual)|Tenaya Therapeutics Inc EPS Diluted (Quarterly) (USD)|Tenaya Therapeutics Inc SG&A Expense (Quarterly) (USD)|Tenaya Therapeutics Inc Shares Outstanding|Tenaya Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Tenaya Therapeutics Inc Ordinary Shares Number (Quarterly)|Tenaya Therapeutics Inc Payout Ratio|Tenaya Therapeutics Inc Quick Ratio (Quarterly)|Tenaya Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Tenaya Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Tenaya Therapeutics Inc Effective Tax Rate (TTM)|Tenaya Therapeutics Inc Return on Equity|Tenaya Therapeutics Inc Net Income (TTM) (USD)|Tenaya Therapeutics Inc Revenue (TTM) (USD)|Tenaya Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Tenaya Therapeutics Inc Revenue (Quarterly) (USD)|Tenaya Therapeutics Inc Gross Profit (Quarterly) (USD)|Tenaya Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Tenaya Therapeutics Inc Net Income (Quarterly) (USD)|Tenaya Therapeutics Inc Net Interest Income (Quarterly) (USD)|Tenaya Therapeutics Inc Price (USD)|Tenaya Therapeutics Inc Total Return Price (USD)|Tenaya Therapeutics Inc Enterprise Value (USD)|Tenaya Therapeutics Inc 30-Day Average Daily Volume|Tenaya Therapeutics Inc 1 Year Price Returns (Daily)|Tenaya Therapeutics Inc Short Interest|Tenaya Therapeutics Inc PE Ratio (Forward)|Tenaya Therapeutics Inc PE Ratio (Forward 1y)|Tenaya Therapeutics Inc PS Ratio (Forward)|Tenaya Therapeutics Inc PS Ratio (Forward 1y)|Tenaya Therapeutics Inc Quarterly EPS Estimates (USD)|Tenaya Therapeutics Inc Quarterly Revenue Estimates (USD)|Tenaya Therapeutics Inc Quarterly EPS Surprise|Tenaya Therapeutics Inc Quarterly Revenue Surprise|Tenaya Therapeutics Inc Quarterly Actual EPS (USD)|Tenaya Therapeutics Inc Quarterly Actual Revenue (USD)|Tenaya Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Tenaya Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Tenaya Therapeutics Inc Price Target (USD)|Tenaya Therapeutics Inc Consensus Recommendation|Tenaya Therapeutics Inc Price Target Num Estimates|Tenaya Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Tenaya Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Tenaya Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Tenaya Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Tenaya Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Tenaya Therapeutics Inc Land and Improvements (Quarterly) (USD)|Tenaya Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Tenaya Therapeutics Inc Other Properties (Quarterly) (USD)|Tenaya Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)
new_0222_0353|TNYA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric
new_0222_0353|TNYA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|monthly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0353|TNYA||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.43971631206|0|0|0|1.4387755102|0|0|1.43971631206|0|15.4166666667|0|91|91|0|0|0|0|0|31|91.3333333333|92|91.3333333333|91.3333333333|16.3333333333|91.4|91|0|0|91.3333333333|91.4|91|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|1.43971631206|1.43971631206|1.43971631206|1.4375|0|15.4166666667|0|0|0|0|91.5|91.5|0|0|0|92|35.25|47|53.3333333333|16|53.3333333333|32|32|91.3333333333|91.3333333333|0|0|0|91|91
new_0222_0353|TNYA||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|141|0|0|0|98|0|0|141|0|12|0|3|3|0|0|0|0|0|1|6|1|6|6|6|5|3|0|0|6|5|3|0|3|0|0|0|0|6|6|6|141|141|141|112|0|12|0|0|0|0|6|6|0|0|0|1|4|3|3|10|3|5|5|6|6|0|0|0|3|3
new_0222_0353|TNYA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly
new_0222_0353|TNYA|202003|202003|202003||||||||||||||||||||||||||||||||||27.2001||-0.3328|1.969||||||-0.3328|||||||||-9.051|-9.051|0.057||||||||||||||||||||||||7.297|0.584|||||
new_0222_0353|TNYA|202006|202006|202006||||||||||||||||||||||||||||||||||27.2001||-0.321|1.914||0||||-0.321|0||||||||-8.731|-8.731|0.018||||||||||||||||||||||||6.958|0.61|||||
new_0222_0353|TNYA|202009|202009|202009||||||||||||||||||||||||||||||||||27.2001||-0.3785|1.972||-0.001||||-0.3785|0.001||||||||-10.295|-10.295|0.007||||||||||||||||||||||||8.48|0.631|||||
new_0222_0353|TNYA|202012|202012|202012|129.964|128.535||17.185||229.476|5.041|224.435||-81.315|-82.812|||||||||||||||1.017|0|||||||27.2001||-0.3793|1.958||0|37.3247|||-0.3793|0|0||-38.395|||||-10.318|-10.318|0.005||||||||||||||||||||||||8.364|0.658||||8.182|0.791
new_0222_0353|TNYA|202103|202103|202103|129.75|128.439||25.682||253.7|5.91|247.79||-93.943|-95.91|||||||||||||||2.092|0|||||||27.2001||-0.48|3.515|||37.3247|||-0.48||0||-42.442|||||-13.098|-13.098|0.009||||||||||||||||||||||||9.59|0.689||||13.091|0.806
new_0222_0353|TNYA|202106|202106|202106|113.222|111.886||37.225||265.431|9.8|255.631||-108.536|-111.12|||||||||||||||5.02|0|||||||37.3247|85|-0.4075|4.331||-0.01|37.3247|||-0.4075|0.01|0||-48.921|||||-15.21|-15.21|0.009|||||||||||-0.5267|0||||0||||||||10.906|0.735||||21.756|0.806
new_0222_0353|TNYA|202107|202106|202106|||||||||||||||-7.7269|||||||0||0|||||||||36.7557|||||39.3247|||||||||||||||||15.35|15.35|491.7481|||0||||||||||||||||||||||||
new_0222_0353|TNYA|202108|202106|202106|||||||||||||||-11.3274|||||||0||0.3694|||||||||42.7163|||||41.1247|||||||||||||||||20.25|20.25|720.8892|||151926|||||||||||0|0|36|1.5|3|-1.9667|-2.0433|||||||
new_0222_0353|TNYA|202109|202109|202109|284.822|280.465||42.897||28.095|13.692|14.403||303.699|-129.382||||-7.5648||||2.8069|||0||2.2361||6.171|0.004|||||||26.8957|100|-0.68|5.356|41.2804|-0.003|41.2804|||-0.68|-188.602|0||-56.888|||||-18.262|-18.262|0.023|20.65|20.65|571.9753|247156.9667||923058|||||-0.48|0|-41.6667||-0.68|0||||1.5||-14.42|-2.1467|12.944|0.746||||21.812|0.806
new_0222_0353|TNYA|202110|202109|202109|||||||||||||||-10.3274||||3.4946|||0||2.6673|||||||||||||||||||||||||||||||25.71|25.71|780.8541|104866.1333||1101070||||||||||||||1.5|||-2.1467|||||||
new_0222_0353|TNYA|202111|202109|202109|||||||||||||||-7.0191||||2.671|||0||3.6326||||||||||||||41.2812|||||||||||||||||19.65|19.65|530.7106|98038.9333||1499589|||||||||||0|0|35.6667|1.5|3|-14.93|-2.63|||||||
new_0222_0353|TNYA|202112|202112|202112|||||||||||||||-6.6369||||2.5758|||0||4.8314|||||||||||||||||||||||||||||||18.95|18.95|501.8137|112573.4667||1994475|||||-0.53|0|||||0||35.6667|1.5|3|-10.8633|-2.63|||||||
new_0222_0353|TNYA|202201|202112|202112|||||||||||||||-2.7987||||1.6203|||0||6.4679|||||||||||||||||||||||||||||||11.92|11.92|211.6069|178200.9333||2670021|||||||||||0|0|31.6667|1.5|3|-2.63|-3.07|||||||
new_0222_0353|TNYA|202202|202112|202112|||||||||||||||-3.3556||||1.7589|||0|||||||||||||||||||||||||||||||||12.94|12.94|253.7137|159961.5||||||||||||||||||||||||||
new_0222_0353|TNYA|202203|202203|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.79|0||||||||||||||||||
new_0222_0353|TNYA|202206|202206|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.86|0||||||||||||||||||
new_0222_0353|TNYA|202209|202209|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.92|0||||||||||||||||||
new_0222_0353|TNYA|202212|202212|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1|0||||||||||||||||||